CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.

Slides:



Advertisements
Similar presentations
Controversies in Screening Recommendations George F. Sawaya, MD Professor of Obstetrics, Gynecology and Reproductive Sciences and Epidemiology and Biostatistics,
Advertisements

Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980– –1984: HPV virus is discovered to cause cervical cancer.
Colorectal Cancer Awareness in TN: Risk Factors, Screening, Outreach Keith D. Gray, M.D. Assistant Professor of Surgery Division of Surgical Oncology The.
Female and Male Cancers
Using Prognosis to Make Screening Decisions Elizabeth Eckstrom, MD, MPH Oregon Health & Science University Hollis Day, MD, MS University of Pittsburgh.
Evidence-based Public Health Interventions Robert S. Lawrence, MD Bloomberg School of Public Health Johns Hopkins University April 20, 2005.
PSA: Fact or Fiction The debate as it stands
 Screening and Immunizations for Women Shannon Boerner, MD May 14, 2013.
Fight Back Against Cancer: Screening and Early Detection
This grey area will not appear in your presentation. Fighting back Against Colon Cancer Presentations prepared by: Canadian Cancer Society, Ontario Division,
Joseph J. Muscato, MD, FACP Medical Director Stewart Cancer Center, Boone Hospital.
EBM Screening Questions. Aim * How to answer evidence based management questions. * To pass Saudi Board Written Exam Insha Allah All of you.
©PPRNet 2014 Designing a PPRNet PCORI Application to Improve Adherence to USPSTF Grade D Recommendations for Cancer Screening.
Breast Cancer Early Detection is Your Best Protection
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
BREAST CANCER SCREENING Anoop Agrawal, M.D.. NEW USPSTF BREAST SCREENING GUIDELINES Published by US Preventative Screening Task Force in November 2009.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
HOW STANDING ORDERS HELPED US IMPROVE CANCER SCREENING: REPORT FROM A NEW PPRNet MEMBER JULIO A SAVINON, MD RIO GRANDE MEDICINE INC. HARLINGEN, TX.
The Burden of Cancer and an Action Plan for Change in Monroe County January 2013 Byron Kennedy, MD, PhD, MPH Deputy Director of Health Monroe County, NY.
Hereditary Factors in Breast Cancer
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
Screening for Lung Cancer Jess Dalehite, M.D. Southwest Medical Imaging Midland Memorial Hospital.
Cancer Screening & Detection. What is cancer screening? What should I ask my doctor about cancer screening? What are the benefits of cancer screening?
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
Prostate Cancer: Education & Outreach Center for Cancer Prevention & Control Prevention and Health Promotion Administration Maryland Department of Health.
Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
Cancer screening Dr V.Mehrzad Hematologist&Oncologist.
January is Cervical Health Awareness Month. Mt. Prospect Health Ministry wants you to know that there’s a lot you can do to prevent cervical cancer.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Eleni Galani Medical Oncologist
Implementation of an evidence-based cancer screening program for an urban disabled population Ryan Goetz BSCh Lewis Cancer & Research Pavilion at St. Joseph’s/
AIMGP Seminar Series January 2004 Joo-Meng Soh Edited by Gloria Rambaldini CANCER SCREENING PART II.
Updates and Controversies in Cancer Screening. Objectives Identify factors important to effective cancer screening. Compare cancer screening guidelines.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
CURRENT NATIONAL PREVENTIVE HEALTH CARE GUIDELINES Juanita Halls, M.D. Professor of Medicine General Internal Medicine University of Wisconsin - UW Health.
Prostate Screening in 2009: New Findings and New Questions Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer.
Screening and Detection in Cancer Survivors
Finding N.E.M.O. Marvin R. Balaan, MD, FCCP System Division Director, Division of Pulmonary and Critical Care Medicine Allegheny Health Network, Pittsburgh.
Cancer Screening 101 What All Adults Should Know Donna L. Milavetz, MD, MPH OnSite Care Medical Director.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
Better Health. No Hassles. Prostate Cancer Month Sokan Hunro, PAC, MPH.
Section 3 Nursing Care Global Thinking  Prevention- broken into two categories  Primary  Secondary  What is the difference between Primary and Secondary.
PROSTATE CANCER PROSTATE CANCER What you should know about Prostate Cancer:  Prostate cancer is the most common type of cancer found in American men,
Population Management Breast Cancer Screening October 2013.
Cancer Prevention Eyad Alsaeed, MD,FRCPC Consultant Radiation Oncology PSHOC KFMC.
Joni Reynolds, RN-CNS, MSN Director of Public Health Programs Winnable Battles: Cancer in Colorado.
COMMON LIFESTYLE DISEASES: CANCER EMS 355 By: Dr. Bushra Bilal.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
Riva L. Rahl, M.D. Cooper Clinic Preventive Medicine Physician Medical Director, Cooper Wellness Program Cancer: Beating the Odds.
The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has.
Rethinking the Check-up. Goals of the Check-up Promote health Identify risk factors Detect disease.
The 21 st - Century Well Woman Exam Honor MacNaughton, MD, Linda Prine, MD, Ruth Lesnewski, MD Beth Israel Institute for Urban Family Health, New York.
Decoding the USPSTF By: Dr Vikram Arora Heritage Valley Health System.
Cancer Education Day Lung Cancer Screening Update Kirenza Francis, MD, FRCPC, DABR Windsor Radiological Associates May 13, 2016.
Health Promotion and Screening WOMEN’S HEALTHCARE: DIAGNOSIS AND MANAGEMENT.
The Importance of Preventative Care
Controversies in Screening
“Living Your Best After Cancer: You and Your Primary Care Doctor Working Together" Mary Helen Hackney, MD Associate Professor of Hematology/Oncology at.
Cancer Screening Guidelines
Cell Biology & Cancer Objective 4
Cancer Screening: Who, When and Why?
Definition of Cancer Screening
Cancer Prevention Screening and Early Detection PROF.MAZIN AL-HAWAZ.
Cancer screening PROF .MAZIN AL-HAWAZ.
Prostate Cancer Screening- Update
Component 1: Introduction to Health Care and Public Health in the U.S.
American Cancer Society Guidelines for the Early Detection of Cancer
Presentation transcript:

CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011

SOURCES OF SCREENING RECOMMENDATIONS American Cancer Society (ACS) American Society of Clinical Oncology (ASCO) National Cancer Institute (NCI) U. S. Preventive Service Task Force (USPSTF) Delaware Cancer Consortium Early Detection and Prevention Committee

U.S. PREVENTIVE SERVICES TASK FORCE (USPSTF) Independent panel of private experts in prevention and PRIMARY CARE  16 Members, Primary Care (including RN), Mostly academic Sponsored by Agency for Health Care Research and Quality (AHRQ)  Public Law Section 915 mandates AHRQ to convene USPSTF  Supported by Evidence Based Practice Center

USPSTF RECOMMENDATIONS Intended for use in Primary Care setting Provides information about the evidence allowing clinicians to make informed decisions about implementation Grades:  A – Strongly Recommend  B – Recommend  C – No Recommendation For or Against  D – Recommend Against  I - Insufficient Evidence For or Against

CLINICIAN USE OF USPSTF GRADES A – Offer and Provide Service B – Offer and Provide Service C – Offer and Provide Service only if other considerations support individual use D - Discourage Use of Service I – Explain Uncertainty of Value of Services

RECOMMENDED CANCER SCREENS FOR AVERAGE RISK INDIVIDUAL (USPSTF GRADE) Recommended Screen Breast: 75 (I – 2009) Uterine Cervical: (A); > 65 years (D – 2003) Colorectal: 50 – 85 years (A); > 85 (D – 2008) Prostate: 75 (D -2008) Lung: ? Not recommended Screen Bladder: (I ) Oral: (I ) Ovary: (D – 2004) Pancreas: (D – 2004) Skin: (I ) Testicle: (D – 2011)

2009 USPSTF BREAST CANCER SCREENING RECOMMENDATIONS Routine Screening Mammogram Ages years – C  Biennial screening mammogram before age 50 should be an individual decision with patient balance of benefits and risk Biennial Screening Mammogram Ages – B Screening Mammogram > Age 75 – I Breast Self Exam – D Clinical Breast Exam (in addition to mammogram) – I Digital Mammogram and Breast MRI - I

DELAWARE CANCER CONSORTIUM BREAST CANCER SCREENING Standard Risk Women should receive Annual mammography starting at age 50 years Standard Risk Women ages 40 to 49 should be offered and encouraged to receive Annual mammography All women should be aware of the limitations of the screening Self Breast and Clinical Breast exam should be performed

Delaware Cancer Consortium Cervical Screening (PAP) AGE (years) Low Risk High Risk* <21 None 18 years 21 – 30 Every 2 years Annual >30 Every 2 years Annual Every 3 years if 3 negative PAPs or Normal PAP and negative HPV >65 Stop if 3 prior negative PAPs in last 10 years & Annual No abnormal in last 10 years *High Risk: early onset of sexual activity, multiple partners, history of STD

Delaware Cancer Consortium Colorectal Screening: Colonoscopy Average Risk: Every 10 years starting at age 50 years Family History of CA: Every 5 years starting at age 40 years Personal History of CA or Polyps: 3 years post polyp removal and then every 5 years Higher Risk (Familial Polyposis, HNPCC, Inflammatory Bowel Disease): Earlier Age of screening and more frequent. Stop Screening > 85 years old

Delaware Cancer Consortium Prostate Screening Promote Education for informed decision Average Risk: offer screening at age 50 years with informed decision High Risk: Encourage screening at age 40 years* or age 45 years** Age > 75 years: Screening less desirable but individualized. No screening if life expectancy < 10 years Screening: PSA + Digital Rectal Exam (DRE) every 1 to 2 years * Several 1 st degree relatives with Prostate CA ** African American, 1 st degree relative < 65, family or personal BRCA 1 or 2

NATIONAL LUNG SCREENING TRIAL Trial published in August, ,000 High Risk Participants (> 30 pack year smoker) Randomized to low dose Chest CT or CXR annually for 3 years Follow-up for additional at least 2 years post screening 20 percent reduction of Lung CA mortality by CT Screening Application to general population including cost effectiveness to be determined

DE CANCER SCREENING RATES (2010 BRFSS) Breast (mammogram): 81% of women > 40 years in last 12 months Cervical (PAP): 83% of women > 18 years in last 36 months Colorectal (colonoscopy): 74% of men & women > 50 years in last 5 years Prostate (PSA): 71% of men > 40 years in last 12 months CONGRATULATIONS DELAWARE !

RESEARCH CURES CANCER